Sort
10,766 grants matching “checkpoint inhibitor”
Mechanisms of ATR Targeting and Regulation
$250,980University Of Wisconsin Madison · R01 · FY2003 · GM
CDK inhibitor regulation during the Xenopus cell cycle
$250,900University Of Texas Hlth Sci Ctr San Ant · R01 · FY2004 · GM
CDK inhibitor regulation during the Xenopus cell cycle
$250,900University Of Texas Hlth Sci Ctr San Ant · R01 · FY2003 · GM
Project 2: Inter-Relationship of Disparities, the Microbiome, Innate Immune System and Immunotherapy Response in Endometrial Cancer
$250,567Victoria Lin Bae-Jump · Univ Of North Carolina Chapel Hill · U54 · FY2025 · CA
Treg-depleting immunotherapy
$250,548Peter David Suzdak · Sonoval Llc · R44 · FY2020 · CA
Structure and Function of SET Domain Methyltransferases
$250,497Raymond C Trievel · University Of Michigan At Ann Arbor · R01 · FY2007 · GM
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
$250,404University Of Arizona · U19 · FY2002 · CA
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
$250,404University Of Arizona · U19 · FY2001 · CA
RNA editing in islet function and inflammation
$250,355Alvin Carter Powers · Vanderbilt University Medical Center · R01 · FY2025 · DK
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2024 · GM
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2023 · GM
Project 4-Monika Rak
$250,347Monika Rak · Lsu Health Sciences Center · P20 · FY2022 · GM
Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer
$250,024Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2022 · CA
P53 MEDIATED G2/M CHECKPOINT CONTROL
$250,024Thomas Jefferson University · R01 · FY2002 · CA
Core 1: Mouse Model and Tissue Biobank Core
$250,014Roger S Lo · Institute For Systems Biology · U54 · FY2023 · CA
Early Clinical Trials of New Anti-Cancer Agents with Phase 1 Emphasis
$250,000Naiyer A Rizvi · Sloan-Kettering Inst Can Research · U01 · FY2008 · CA
Tumor-associated pDC (TApDC) and HIV infection in programing tumor microenvironment
$249,999Taofeek K Owonikoko · University Of Maryland Baltimore · P30 · FY2024 · CA
Checkpoint Abrogation and MEK 1/2 Inhibition in Myeloma
$249,983Steven Grant · Virginia Commonwealth University · R01 · FY2009 · CA
Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer
$249,940Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2010 · CA
Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer
$249,940Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2009 · CA
A novel oncolytic virus for pancreatic cancer immunotherapy
$249,900Omeed Moaven · Lsu Health Sciences Center · P20 · FY2024 · GM
Functional study of C53 protein as a novel regulator of checkpoint kinases
$249,900Honglin Li · Lurie Children'S Hospital Of Chicago · R01 · FY2009 · GM
Consolidated Basic Cancer Research Program
$249,893Dario C. Altieri · Wistar Institute · P30 · FY2023 · CA
Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$249,806Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2020 · CA
Molecular basis of neuronal dysfunction in AIDS
$249,728Francesca Peruzzi · Temple Univ Of The Commonwealth · R01 · FY2008 · MH